By Loxo Oncology | November 22, 2017

Loxo Oncology & Bayer Form Development Partnership for Larotrectinib and LOXO-195

By Loxo Oncology | June 5, 2017

Loxo Oncology Reveals Proof-of-Concept Data for LOXO-195